A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
Condition(s):GliomaLast Updated:January 20, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):GliomaLast Updated:January 20, 2010Unknown status
Condition(s):GliomaLast Updated:January 20, 2010Unknown status
Condition(s):Adult-Onset GliomaLast Updated:January 20, 2010Completed
Condition(s):Malignant GliomaLast Updated:January 20, 2010Completed
Condition(s):Newly Diagnosed Supratentorial Malignant GliomaLast Updated:October 31, 2007Unknown status
Condition(s):CancerLast Updated:January 20, 2010Terminated
Condition(s):Non-Small Cell Lung CancerLast Updated:October 31, 2007Completed
Condition(s):Non-small Cell Lung Cancer; Extensive Stage UnresectableLast Updated:January 20, 2010Terminated
Condition(s):Brain Neoplasm, Primary; Brain Neoplasms, Malignant; Brain Neoplasms, BenignLast Updated:February 21, 2021Terminated
Condition(s):Nonresectable Adrenocortical CarcinomaLast Updated:May 17, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.